Arena’s Anti-Obesity Drug Gets Commercial Partner before Approval Decision
By Staff Editor;
Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)
Published: 2 Sep-2010
DOI: 10.3833/pdr.v2010.i7.1356 ISSN: 1756-7874
Section: Distribution & Marketing
Fulltext:
Abstract
Arena Pharmaceuticals has finally found a US commercial partner for its anti-obesity drug lorcaserin, which is currently awaiting regulatory approval from the FDA, by signing a marketing and supply agreement with Eisai...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS